S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
Log in

HIVE Blockchain Technologies Stock Forecast, Price & News

-0.14 (-3.10 %)
(As of 03/2/2021 12:00 AM ET)
Today's Range
Now: $4.37
50-Day Range
MA: $2.91
52-Week Range
Now: $4.37
Volume4.44 million shs
Average Volume6.91 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
HIVE Blockchain Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. It is involved in the mining and sale of digital currencies, such as Ethereum, Ethereum Classic, and Bitcoin. The company was formerly known as Leeta Gold Corp. and changed its name to HIVE Blockchain Technologies Ltd. in September 2017. HIVE Blockchain Technologies Ltd. was incorporated in 1987 and is headquartered in Vancouver, Canada.
HIVE Blockchain Technologies logo


See More Headlines

Industry, Sector and Symbol

Industry Capital Markets
Phone604 664 1078
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.00 out of 5 stars

Financial Services Sector

517th out of 625 stocks

Capital Markets Industry

16th out of 17 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
-0.14 (-3.10 %)
(As of 03/2/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HVBTF News and Ratings via Email

Sign-up to receive the latest news and ratings for HVBTF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

HIVE Blockchain Technologies (OTCMKTS:HVBTF) Frequently Asked Questions

What stocks does MarketBeat like better than HIVE Blockchain Technologies?

Wall Street analysts have given HIVE Blockchain Technologies a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but HIVE Blockchain Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting HIVE Blockchain Technologies?

HIVE Blockchain Technologies saw a drop in short interest in the month of February. As of February 12th, there was short interest totaling 413,300 shares, a drop of 51.5% from the January 28th total of 852,300 shares. Based on an average daily volume of 7,005,700 shares, the short-interest ratio is currently 0.1 days.
View HIVE Blockchain Technologies' Short Interest

Who are HIVE Blockchain Technologies' key executives?

HIVE Blockchain Technologies' management team includes the following people:
  • Mr. Frank Edward Holmes, Interim CEO & Exec. Chairman (Age 66)
  • Mr. Olivier Roussy Newton, Founder & Strategic Advisor
  • Mr. Darcy Daubaras, Chief Financial Officer

Who are some of HIVE Blockchain Technologies' key competitors?

What is HIVE Blockchain Technologies' stock symbol?

HIVE Blockchain Technologies trades on the OTCMKTS under the ticker symbol "HVBTF."

How do I buy shares of HIVE Blockchain Technologies?

Shares of HVBTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is HIVE Blockchain Technologies' stock price today?

One share of HVBTF stock can currently be purchased for approximately $4.37.

What is HIVE Blockchain Technologies' official website?

The official website for HIVE Blockchain Technologies is www.hiveblockchain.com.

How can I contact HIVE Blockchain Technologies?

The company can be reached via phone at 604 664 1078.

This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.